Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling

Nanomedicine (Lond). 2023 Mar;18(7):583-587. doi: 10.2217/nnm-2023-0032. Epub 2023 May 17.
No abstract available

Keywords: P53; asthma; chronic obstructive pulmonary disease; drug delivery; inflammation; lung; lung cancer; lung injury; nanoparticle; pulmonary fibrosis.

MeSH terms

  • Humans
  • Lung
  • Lung Diseases* / drug therapy
  • Pulmonary Disease, Chronic Obstructive*
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Tumor Suppressor Protein p53